Evidence map›Paper›PMID 28095807›Full record

Trial reportBMC pediatrics2017

Comparison of developmental milestone attainment in early treated HIV-infected infants versus HIV-unexposed infants: a prospective cohort study.

Sarah Benki-Nugent, Dalton Wamalwa, Agnes Langat, Kenneth Tapia, Judith Adhiambo, Daisy Chebet, Helen Moraa Okinyi, Grace John-Stewart

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00428116 (Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00428116 naterminatednot on this map

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya (0-4.5 Month Randomized Controlled Trial)

TypeinterventionalSponsorUniversity of WashingtonRan2007 to 2014Enrolled140ConditionsHIV InfectionsArmsHAART
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Neurocognitive Complications of Pediatric HIV Infections.Current topics in behavioral neurosciences · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Implications of Combined Exposure to Household Air Pollution and HIV on Neurocognition in Children.International journal of environmental research and public health · 2018
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah Benki-NugentDepartment of Global Health, University of Washington, Box 359909, 325 9th Ave., Seattle, WA, 98104, USA. benki@u.washington.edu.ORCID 0000-0002-3034-8257
Dalton WamalwaDepartment of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Agnes LangatDepartment of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Kenneth TapiaDepartment of Global Health, University of Washington, Box 359909, 325 9th Ave., Seattle, WA, 98104, USA.
Judith AdhiamboDepartment of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Daisy ChebetDepartment of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Helen Moraa OkinyiDepartment of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Grace John-StewartDepartment of Global Health, University of Washington, Box 359909, 325 9th Ave., Seattle, WA, 98104, USA.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infectionsR01HD023412 · NICHD · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart, DALTON CHEKOKO WAMALWA · 1987 to 2026
$12.2M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
Impact of HIV, immune activation, and ART on child neurodevelopment in KenyaK01NS080637 · NINDS · UNIVERSITY OF WASHINGTON · PI BENKI-NUGENT, SARAH F. · 2012 to 2016
$848k
Long-term efficacy of pediatric HAARTR01TW007632 · FIC · UNIVERSITY OF NAIROBI · PI WAMALWA, DALTON CHEKOKO · 2006 to 2010
$352k
FIC NIH HHS R01 TW007632NIAID NIH HHS P30 AI027757NICHD NIH HHS K24 HD054314NICHD NIH HHS R01 HD023412NINDS NIH HHS K01 NS080637
6 · The paper itself

Abstract

backgroundInfant HIV infection is associated with delayed milestone attainment. The extent to which effective antiretroviral therapy (ART) prevents these delays is not well defined.

methodsAges at attainment of milestones were compared between HIV-infected (initiated ART by age <5 months), and HIV-unexposed uninfected (HUU) infants. Kaplan Meier analyses were used to estimate and compare (log-rank tests) ages at milestones between groups. Adjusted analyses were performed using Cox proportional hazards models.

resultsSeventy-three HIV-infected on ART (median enrollment age 3.7 months) and 92 HUU infants (median enrollment age 1.6 months) were followed prospectively. HIV-infected infants on ART had delays in developmental milestone attainment compared to HUU: median age at attainment of sitting with support, sitting unsupported, walking with support, walking unsupported, monosyllabic speech and throwing toys were each delayed (all p-values <0.0005). Compared with HUU, the subset of HIV-infected infants with both virologic suppression and immune recovery at 6 months had delays for speech (delay: 2.0 months; P = 0.0002) and trend to later walking unsupported. Among HIV-infected infants with poor 6-month post-ART responses (lacking viral suppression and immune recovery) there were greater delays versus HUU for: walking unsupported (delay: 4.0 months; P = 0.0001) and speech (delay: 5.0 months; P < 0.0001).

conclusionsHIV infected infants with viral suppression on ART had better recovery of developmental milestones than those without suppression, however, deficits persisted compared to uninfected infants. Earlier ART may be required for optimized cognitive outcomes in perinatally HIV-infected infants.

trial registrationNCT00428116 ; January 22, 2007.

Indexed as

HIV-1Anti-HIV AgentsCase-Control StudiesDevelopmental DisabilitiesDrug Therapy, CombinationFemaleFollow-Up StudiesHIV InfectionsHumansInfantKaplan-Meier EstimateMaleProportional Hazards ModelsProspective StudiesTreatment OutcomeAnti-HIV AgentsAntiretroviral therapyEarly antiretroviral therapyHIVInfantNeurodevelopmentSub-Saharan Africa

Identifiers

PMID28095807
PMCPMC5240280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.